Eli Lilly (LLY.N) announced results from a second obesity trial of orforglipron, showing the drug reduced weight by 9.6% in patients with obesity and diabetes. The company plans to apply for approval of the weight loss drug in 2025.

2025-08-26 18:54:28

weight loss drug Lilly

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Qualcomm (QCOM.O) CEO: Qualcomm needs more energy-efficient chips.
                            2025-09-06

                                    Apple releases N1 chip
                            2025-09-10

                                    The value of projects signed at the 2025 Smart Expo exceeds 200 billion yuan
                            2025-09-05

                                    Challenger Gray, a US employment consulting firm, reports that pharmaceutical companies announced plans to lay off 19,112 employees in August, bringing the total to 22,433. This represents a 142% increase compared to the 9,254 layoffs reported in the same period last year. The industry is facing increasing competition from patent expirations and is refocusing on higher-margin products. Many companies are also implementing artificial intelligence, which is leading to restructuring and job losses.
                            2025-09-04

                                    Market News: The European Union fined Google nearly €3 billion for its dominant market position in advertising technology, ordering it to end conflicts of interest in advertising technology. Google was given 60 days to explain how it will comply with EU regulations.
                            2025-09-05